Tabuchi Y, Tsujimoto M, Yamamoto K, Kosaka T, et al. Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen. Cancer Chemother Pharmacol 2022 Nov 19. doi: 10.1007/s00280-022-04492.
PMID: 36401659